康哲药业(00867.HK)磷酸芦可替尼乳膏香港新药上市申请获批

阿斯达克财经
06 Nov 2024

康哲药业(00867.HK) 公布,香港政府药剂业及毒药管理局批准磷酸芦可替尼乳膏新药上市申请。该产品用于治疗12岁及以上青少年和成人患者伴面部受累的非节段型白癜风。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-05 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10